Press "Enter" to skip to content

FDA Grants Priority Review to Niraparib for Late-Stage Ovarian Cancer Treatment – www.oncnursingnews.com/

admin 0

FDA Grants Priority Review to Niraparib for Late-Stage Ovarian Cancer Treatment  www.oncnursingnews.com/

The FDA has granted a priority review designation to a supplemental biologics license application for niraparib (Zejula) for the treatment of patients with …

“ovarian cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *